Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-05

Clinical Trial Update: Effect of Intraperitoneal Dexmedetomidine Added to Bupivacaine 0.25% Versus Bupivacaine Alone on Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy [NA]

View source ↗

Summary

A completed clinical trial comparing intraperitoneal dexmedetomidine added to 0.25% bupivacaine versus bupivacaine alone for postoperative analgesia in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Ain Shams University | Conditions: Postoperative Pain Management, Cholelithiasis | NA | Status: COMPLETED